| Adult Solid Neoplasm studied in …STUDIED_INderived200 of 1,164show all (up to 200) |
|---|
| → studied in | NCT06098651Phase 1 · completed A Study of DCR-STAT3 in Adults With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788509Phase 1 · enrolling by invitation A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088004Phase 1/Phase 2 · recruiting Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915753Phase 1 · recruiting Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221204Phase 1 · completed A Monotherapy in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714617Phase 1 · terminated Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228247Phase 1/Phase 2 · recruiting A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088472Phase 1 · active not recruiting TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06398418Phase 1 · recruiting R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07396584Phase 1/Phase 2 · recruiting HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974738Phase 1 · active not recruiting A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04165772Phase 2 · recruiting Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05230186completed A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells. · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05430373Phase 1 · recruiting GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01375829Phase 1 · active not recruiting Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739696NA · active not recruiting Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients. · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06292845NA · recruiting Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225088NA · recruiting DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625775Phase 1 · recruiting Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878163Phase 1 · active not recruiting GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04015609NA · recruiting Psychotherapy Intervention for Latinos With Advanced Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04537936NA · recruiting Psychotherapy Intervention for Latinos With Adv Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04243499Phase 1/Phase 2 · active not recruiting First-in-Human Study of ICT01 in Patients With Advanced Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980506temporarily not available MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07361562Phase 1 · recruiting A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06337084Phase 1 · active not recruiting Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617169Phase 1 · active not recruiting Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04913285Phase 1 · recruiting A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864144Phase 1/Phase 2 · completed A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05868226Phase 1/Phase 2 · recruiting PRE-ISPY Phase I/II Oncology Platform Program · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06507306Phase 1 · active not recruiting A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895681withdrawn UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05958121Phase 1/Phase 2 · recruiting IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06462794Phase 1 · recruiting First In Human Study of CX-801 in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383506Phase 1 · recruiting A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902872Phase 1/Phase 2 · completed Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04725474Phase 1/Phase 2 · active not recruiting First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06059547Phase 2 · completed Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07246863Phase 2 · recruiting Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04928508Phase 1 · active not recruiting Advanced or Recurrent Solid Tumors Treated With SHetA2 · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045201Phase 1 · active not recruiting Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03656172completed Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07139990Phase 1 · recruiting Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03987555suspended Paclitaxel Therapeutic Drug Monitoring in Cancer Patients · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02290522NA · recruiting Copenhagen Prospective Personalized Oncology (CoPPO) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00935090active not recruiting 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07098988Phase 2 · recruiting Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06506643Phase 1/Phase 2 · recruiting Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07256756Phase 1 · recruiting A Study of GC203 TIL in Advanced Solid Tumors (NF) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07294872Phase 1 · not yet recruiting A Study of TIL in Advanced Solid Tumors (CZ) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06380660Phase 1/Phase 2 · active not recruiting Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05307874Phase 1/Phase 2 · terminated Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03915678Phase 2 · active not recruiting Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06614140Phase 1/Phase 2 · completed Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718581Phase 1/Phase 2 · not yet recruiting HMPL-A830 in Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00992303recruiting Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06265688Phase 1 · recruiting First In Human Study of CX-2051 in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07487805Phase 2 · not yet recruiting Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04130516Phase 1/Phase 2 · active not recruiting Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112565Phase 1 · active not recruiting RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04328844Phase 1 · active not recruiting A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768139Phase 1/Phase 2 · recruiting First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06403436Phase 1 · completed A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06824363early Phase 1 · recruiting ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05887492Phase 1/Phase 2 · active not recruiting Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02088775NA · completed PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04942717NA · recruiting Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01137825recruiting Registry of Older Patients With Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03919292Phase 1/Phase 2 · suspended Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04673942Phase 2 · active not recruiting A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05763004Phase 1 · completed A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05861895Phase 1 · recruiting HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04219254Phase 1/Phase 2 · recruiting A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05620472Phase 1 · completed Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1 · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07664397Phase 1 · not yet recruiting Imaging Study of [89Zr]DFO-YS5 for Cancer Detection · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06104488Phase 1 · active not recruiting A Study of Avutometinib for People With Solid Tumor Cancers · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06051695Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06554795Phase 1/Phase 2 · recruiting First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04621435Phase 1 · recruiting Imaging of Solid Tumors Using FAP-2286 · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03823144NA · recruiting Intravital Microscopy in Human Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06917079Phase 1 · recruiting BBO-11818 in Adult Subjects With KRAS Mutant Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04552288Phase 2 · completed Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06598007Phase 1/Phase 2 · recruiting A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06977737Phase 1/Phase 2 · recruiting A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06885424enrolling by invitation A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05678010Phase 1 · active not recruiting A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03686124Phase 1/Phase 2 · recruiting ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05036226Phase 1/Phase 2 · recruiting COAST Therapy in Advanced Solid Tumors and Prostate Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05582850Phase 1 · terminated DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01705548NA · completed Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07159828Phase 1 · terminated A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05865990Phase 2 · completed HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05359445Phase 1 · active not recruiting IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020221Phase 1/Phase 2 · recruiting A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281176Phase 1 · active not recruiting High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06326411Phase 1 · recruiting A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05605119Phase 1 · terminated First in Human, Dose Escalation, Dose Expansion Study of AUR105 · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607199Phase 1 · terminated A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05071846Phase 1 · active not recruiting MVX-ONCO-2 in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03594422Phase 1 · recruiting A Study of HQP1351 in Patients With GIST or Other Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06444815Phase 1 · recruiting A Study of VET3-TGI in Patients With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05752552Phase 1 · recruiting Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665206Phase 1/Phase 2 · recruiting Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05223608NA · recruiting Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00477958NA · active not recruiting Assessment Tool for Older Patients With Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00900471recruiting Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00571389recruiting A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04143711Phase 1/Phase 2 · completed Study of DF1001 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04443088Phase 1 · recruiting An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05689853Phase 1/Phase 2 · recruiting Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06108479Phase 1 · completed Study of DF6215 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06244771Phase 1/Phase 2 · recruiting A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05888532Phase 1/Phase 2 · recruiting 64Cu-GRIP B in Patients With Advanced Malignancies · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06391918Phase 1 · terminated Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07417189Phase 1/Phase 2 · recruiting A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04705818Phase 2 · completed Combining Epigenetic And Immune Therapy to Beat Cancer. · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05346484Phase 1 · terminated A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06063317Phase 1 · terminated A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343460Phase 3 · completed APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137195NA · active not recruiting Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05381909Phase 1 · terminated A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03445858early Phase 1 · completed Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04041310Phase 1/Phase 2 · active not recruiting Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04932525NA · recruiting Gustave Roussy Cancer Profiling · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03465592Phase 1/Phase 2 · recruiting Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06772090NA · not yet recruiting Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02432963Phase 1 · active not recruiting Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy · condition mapped ONTOLOGY_EXACT · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06397963NA · recruiting Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04504942Phase 2 · completed Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153094NA · active not recruiting Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276284Phase 1/Phase 2 · completed Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04587479Phase 1 · completed A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05651022Phase 1/Phase 2 · active not recruiting Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544552Phase 1/Phase 2 · active not recruiting Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06265727Phase 1/Phase 2 · recruiting A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03905148Phase 1 · completed Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07152353NA · active not recruiting Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04353375Phase 2/Phase 3 · recruiting HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02215928recruiting Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573310Phase 1 · completed A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05856981Phase 1 · recruiting Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383884Phase 2 · recruiting Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05147272Phase 1 · terminated Study of RP-6306 With Gemcitabine in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439888Phase 1/Phase 2 · recruiting Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05586321Phase 1 · completed Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05631899Phase 1 · active not recruiting CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504368Phase 1 · recruiting Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04643418Phase 1/Phase 2 · recruiting Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04972110Phase 1/Phase 2 · terminated Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05597839Phase 1/Phase 2 · completed Study of DF9001 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06228326Phase 1/Phase 2 · recruiting A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04954599Phase 1/Phase 2 · recruiting Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06264921Phase 1 · terminated A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05216432Phase 1 · recruiting First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06270082Phase 1 · terminated Study of IK-595 in RAS- or RAF-altered Advanced Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05055609Phase 1 · recruiting Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06682793Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05723640Phase 1 · completed The Safety and Dosimetry Study of 177Lu-LNC1004 Injection · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05114668Phase 1 · completed Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00712712Phase 2 · completed Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04169321Phase 1 · completed Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03084757NA · completed SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220556NA · completed Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03410121NA · completed Comparison of Humeral or Thoracic Implantation of an Central Veinous Access by an Implantable Venous Access Device in Patients With Solid Tumors Requiring Chemotherapy · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03729596Phase 1/Phase 2 · terminated MGC018 With or Without MGA012 in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02775292Phase 1 · completed Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 · condition mapped ONTOLOGY_EXACT · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04306900Phase 1 · completed TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04729348Phase 2 · terminated Pembrolizumab And Lenvatinib In Leptomeningeal Metastases · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03772561Phase 1 · recruiting Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01843413Phase 1 · active not recruiting Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04577963Phase 1/Phase 2 · terminated A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03520075Phase 1/Phase 2 · completed Study of ASTX029 in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540982Phase 1/Phase 2 · completed Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03990233Phase 1 · completed A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05354323Phase 1 · active not recruiting NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05481502NA · recruiting An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03094169Phase 1/Phase 2 · terminated AVID100 in Advanced Epithelial Carcinomas · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04100694approved for marketing Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04927663Phase 1 · terminated 11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04899505completed Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05759949Phase 1 · completed First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05242822Phase 1 · terminated A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02153151completed Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238355Phase 2 · terminated Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05736731Phase 1/Phase 2 · active not recruiting A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05840510Phase 1 · terminated Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05435339Phase 1/Phase 2 · terminated A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06462716Phase 1 · unknown A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06916442not yet recruiting Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06911333Phase 1/Phase 2 · recruiting AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895733Phase 1/Phase 2 · recruiting Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1) · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06897228Phase 1 · recruiting PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06883539Phase 1 · recruiting A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. · condition mapped ALIAS · 1,164 trials mapped (161 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |